{"id":"https://openalex.org/W4416933731","doi":"https://doi.org/10.1007/s00280-025-04836-y","title":"Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer","display_name":"Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer","publication_year":2025,"publication_date":"2025-12-01","ids":{"openalex":"https://openalex.org/W4416933731","doi":"https://doi.org/10.1007/s00280-025-04836-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/41331382","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12672692"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-025-04836-y","doi":"https://doi.org/10.1007/s00280-025-04836-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-025-04836-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-025-04836-y.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00280-025-04836-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Martina Catalano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Martina Catalano","raw_affiliation_strings":["Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120679299","display_name":"Gestiana Cekrezi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gestiana Cekrezi","raw_affiliation_strings":["School of Medicine and Surgery, University of Florence, Florence, 50134, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine and Surgery, University of Florence, Florence, 50134, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017244484","display_name":"Irene De Gennaro Aquino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Irene De Gennaro Aquino","raw_affiliation_strings":["Clinical Oncology, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Delia Ravizza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Delia Ravizza","raw_affiliation_strings":["Clinical Oncology, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexandra Paulet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alexandra Paulet","raw_affiliation_strings":["Clinical Oncology, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117723305","display_name":"Kristian Shtembari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Kristian Shtembari","raw_affiliation_strings":["Clinical Oncology, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039800393","display_name":"Claudia De Angelis","orcid":"https://orcid.org/0000-0003-0398-5610","observed_orcids":["https://orcid.org/0000-0003-0398-5610"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia De Angelis","raw_affiliation_strings":["Medical Oncology Unit, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047413929","display_name":"Roberto Petrioli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Petrioli","raw_affiliation_strings":["Unit of Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, 53100, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, 53100, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020078965","display_name":"Daniele Generali","orcid":"https://orcid.org/0000-0003-2480-3855","observed_orcids":["https://orcid.org/0000-0003-2480-3855"]},"institutions":[{"id":"https://openalex.org/I142444530","display_name":"University of Trieste","ror":"https://ror.org/02n742c10","country_code":"IT","type":"education","lineage":["https://openalex.org/I142444530"]},{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]},{"id":"https://openalex.org/I4396570609","display_name":"Azienda Socio Sanitaria Territoriale di Cremona","ror":"https://ror.org/02h6t3w06","country_code":"IT","type":"government","lineage":["https://openalex.org/I4396570609"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Generali","raw_affiliation_strings":["Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy","Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy","institution_ids":["https://openalex.org/I142444530"]},{"raw_affiliation_string":"Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579","https://openalex.org/I4396570609"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037756908","display_name":"Giandomenico Roviello","orcid":"https://orcid.org/0000-0001-5504-8237","observed_orcids":["https://orcid.org/0000-0001-5504-8237","https://orcid.org/0000-0002-5185-6701"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giandomenico Roviello","raw_affiliation_strings":["Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy. giandomenico.roviello@unifi.it","Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy. giandomenico.roviello@unifi.it","institution_ids":["https://openalex.org/I45084792"]},{"raw_affiliation_string":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy","institution_ids":["https://openalex.org/I45084792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5037756908"],"corresponding_institution_ids":["https://openalex.org/I45084792"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":1.5676,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.81815121,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"95","issue":"1","first_page":"117","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8889999985694885},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.9070000052452087},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":1.0},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.8709999918937683},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9279999732971191},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/adverse-event-management","display_name":"adverse event management","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8300999999046326},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7706999778747559},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6162999868392944},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5989999771118164},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5175999999046326},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.48249998688697815},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3571999967098236},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3422999978065491},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33970001339912415},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3343000113964081},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.3093999922275543},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.29499998688697815},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2768999934196472},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.266400009393692}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051361","descriptor_name":"Cyclin-Dependent Kinase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00280-025-04836-y","doi":"https://doi.org/10.1007/s00280-025-04836-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-025-04836-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-025-04836-y.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:41331382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41331382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12672692","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12672692/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemother Pharmacol","raw_type":"Text"},{"id":"pmh:oai:flore.unifi.it:2158/1452159","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2158/1452159","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s00280-025-04836-y","doi":"https://doi.org/10.1007/s00280-025-04836-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-025-04836-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-025-04836-y.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322648","display_name":"Universit\u00e0 degli Studi di Firenze","ror":"https://ror.org/04jr1s763"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416933731.pdf","grobid_xml":"https://content.openalex.org/works/W4416933731.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1464936406","https://openalex.org/W2019607817","https://openalex.org/W2042941276","https://openalex.org/W2070780645","https://openalex.org/W2159427817","https://openalex.org/W2528767298","https://openalex.org/W2552099557","https://openalex.org/W2763875663","https://openalex.org/W3116228263","https://openalex.org/W4315754639","https://openalex.org/W4392926580","https://openalex.org/W4399859560","https://openalex.org/W4402508109","https://openalex.org/W4403615037","https://openalex.org/W4404638136","https://openalex.org/W4405219705","https://openalex.org/W4406074219","https://openalex.org/W4407294081","https://openalex.org/W4409308524"],"related_works":["https://openalex.org/W4390884204","https://openalex.org/W6921351972","https://openalex.org/W4229443358","https://openalex.org/W4401345937","https://openalex.org/W7125941391","https://openalex.org/W4414787188","https://openalex.org/W4391613717","https://openalex.org/W4385554041","https://openalex.org/W4386933973","https://openalex.org/W4410193004"],"abstract_inverted_index":{"BACKGROUND:":[0],"CDK4/6":[1,63,163],"inhibitors":[2,64,164],"have":[3,165],"transformed":[4],"treatment":[5],"for":[6,152,177,183],"HR":[7,192],"+":[8,56,193],"HER2":[9,57,194],"-":[10,58,195],"advanced":[11],"breast":[12],"cancer":[13],"(aBC).":[14],"However,":[15],"adverse":[16],"events":[17],"(AEs)":[18],"often":[19],"lead":[20],"to":[21,124,128,187],"dose":[22,173],"adjustments":[23,174],"or":[24,46],"discontinuation,":[25],"potentially":[26],"impacting":[27],"outcomes.":[28],"This":[29],"study":[30,52],"assessed":[31],"AE":[32,73,170,184],"incidence":[33],"and":[34,78,112,139,159,172],"its":[35],"effect":[36],"on":[37],"survival":[38,76,80],"in":[39,99,109,191],"patients":[40,60,86],"receiving":[41],"abemaciclib":[42],"(AB),":[43],"ribociclib":[44],"(RB),":[45],"palbociclib":[47],"(PB).":[48],"METHODS:":[49],"A":[50],"retrospective":[51],"of":[53,94,101],"162":[54],"h":[55],"aBC":[59],"treated":[61],"with":[62,90,103],"as":[65],"first-line":[66],"therapy":[67],"(July":[68],"2017-September":[69],"2024)":[70],"was":[71,150],"conducted.":[72],"incidence,":[74],"progression-free":[75],"(PFS),":[77],"overall":[79],"(OS)":[81],"were":[82,88,126],"analyzed.":[83],"RESULTS:":[84],"Most":[85],"(91.4%)":[87],"postmenopausal,":[89],"a":[91],"median":[92],"follow-up":[93],"24.6":[95],"months.":[96],"AEs":[97,125],"occurred":[98],"87%":[100],"patients,":[102],"grade":[104],"3-4":[105],"neutropenia":[106],"most":[107],"common":[108],"PB":[110,153],"(79.3%)":[111],"RB":[113,157],"(80%),":[114],"while":[115],"AB":[116,160],"caused":[117],"more":[118],"diarrhea":[119],"(66.7%).":[120],"Dose":[121],"reductions":[122],"due":[123],"linked":[127],"significantly":[129],"longer":[130],"PFS":[131],"(38.5":[132],"vs.":[133,142],"16.3":[134],"months,":[135,144],"p":[136,145],"<":[137],"0.001)":[138],"OS":[140],"(NR":[141],"32.4":[143],"=":[146],"0.024).":[147],"Treatment":[148],"discontinuation":[149],"highest":[151],"(19.6%),":[154],"followed":[155],"by":[156],"(16.9%)":[158],"(14.9%).":[161],"CONCLUSIONS:":[162],"distinct":[166],"toxicity":[167],"profiles.":[168],"Effective":[169],"management":[171],"are":[175],"crucial":[176],"maintaining":[178],"efficacy,":[179],"emphasizing":[180],"the":[181],"need":[182],"prediction":[185],"models":[186],"optimize":[188],"CDK4/6i":[189],"use":[190],"aBC.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-12-03T00:00:00"}